April 17 (Reuters) - Generic drugmaker Mylan NV moved quickly on Friday to pour cold water on published reports that Teva Pharmaceuticals Industries is considering a bid to acquire it.
Mylan last week announced a $29 billion offer to buy Perrigo Co Plc in a move that some analysts suggested was a tactic to help fend off an acquisition by larger rival Teva.
22:56 Yahoo says Verizon buyout delayed but still on17
01:45 Japanese shares fall 1% as yen strengthens, Samsung presser announcements ahead18
19:39 $1M '100 percent Swiss Made' watch made of real Swiss cheese16
21:52 Netflix nears 94 million subscribers 10 years after streaming launch20